Delfi Diagnostics to Showcase Breadth of its Next-Generation Liquid Biopsy Platform at the American Association for Cancer Research Annual Meeting

BALTIMORE and PALO ALTO, Calif., March 14, 2023 /PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, will present multiple oral and poster presentations showcasing the...

Click to view original post